Clinical utility of freehand TRUS guided transperineal biopsy with" 12 + X"cores

He ZHU,Hongfeng GUO,Ningchen LI,Yanqun NA
DOI: https://doi.org/10.13201/j.issn.1001-1420.2018.02.019
2018-01-01
Journal of Clinical Urology
Abstract:Objective:To evaluate the clinical value of the detection of prostate carcinoma with freehand TRUS guided transperineal biopsy with "12+X" cores in patients with elevated prostate-specific antigen.Method:From December 2014 to December 2015,a total of 74 patients with suspected prostate carcinoma were detected.Of these,24 patients had an nodule on digital rectal examination,14 patients had an abnormal echo of transabdominal or transrectal ultrasonography,30 patients had a low signal area on magnetic resonance imaging.Freehand TRUS guided transperineal biopsy was performed with "12+X" cores.We futher peformed a targeted 1-to 2-core biopsy.A retrospective analysis of the institutional registry for detection rates and complications was done.Result:Freehand TRUS guided transperineal biopsy with "12 + X" cores was successfully performed in all 74 patients.The median age was 72 (range,43-81) years old,and median prostate-specific antigen was 17.8 (range,1.9-500)ng/ml.Transperineal biopsy identified cancer in 31.1% (23/74) patients and the rates of detection of clinically significant and insignificant cancer according to the several definitions used were 30.4 % and 56.5 %,respectively.Among the negative biopsies,3 had the final diagnosis of prostate carcinoma after TURP and 2 after secondary biopsy.Complications such as gross hematuria (8.1%),fever (6.8%) and discomfort of perineal region (2.7%) were found without other serious complications.Conclusion:Freehand TRUS guided transperineal biopsy with "12+X" cores appears to be an effective biopsy protocol for the detection of prostate carcinoma.
What problem does this paper attempt to address?